Alla Bourlatskii, | |
175 Jefferson St, Fairfield, CT 06825-1078 | |
(203) 365-6443 | |
Not Available |
Full Name | Alla Bourlatskii |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 175 Jefferson St, Fairfield, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336511401 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 004954 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alla Bourlatskii, 175 Jefferson St, Fairfield, CT 06825-1078 Ph: () - | Alla Bourlatskii, 175 Jefferson St, Fairfield, CT 06825-1078 Ph: (203) 365-6443 |
News Archive
Accumulating research indicates that melatonin has a major role in pain transmission and has an ultra-sensitizing effect. Dr. Fang Huang and colleagues from Sun Yat-sen University in China for the first time located the distribution of melatonin receptor 1 in the caudal spinal trigeminal nucleus.
Researchers at Sanford Burnham Prebys Medical Discovery Institute have published a study in Nature Communications shedding new light on how K-80003 (TX803), an anti-cancer agent discovered at the Institute, prevents activation of the PI3K pathway, resulting in inhibition of cancer cell growth.
Findings by scientists from the Max F. Perutz Laboratories (MFPL) of the University of Vienna and the Medical University of Vienna reveal a surprising role for histone deacetylase 1 (HDAC1) - a member of a family of chromatin modifying proteins - in the development of skin tumors.
According to U.S. mortality data the overall death rate from unintentional injury among children and teens fell 29% from 2000 to 2009. What was concerning however, was that rates of death by poisoning in young adults - mostly from prescription drug overdose - and suffocation in infants rose. And unintentional injury still accounted for 37% of all deaths in the 19-and-under age group in 2009 and was the fifth leading killer of patients younger than 1, the report said. The CDC report was published in the April 16 issue of Morbidity and Mortality Weekly Report.
pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced financial results for its second quarter ended December 31, 2013.
› Verified 9 days ago
Mrs. Amanda Bean, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1300 Post Rd Ste 204, Fairfield, CT 06824 Phone: 203-255-3669 | |
Caroline Marie Murphy, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2228 Black Rock Tpke Ste 201, Fairfield, CT 06825 Phone: 203-908-4433 Fax: 203-908-4449 | |
Mrs. Carol Landsman, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1931 Black Rock Tpke, Fairfield, CT 06825 Phone: 203-384-8681 Fax: 203-384-0722 | |
Kaitlyn Boorin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 55 Walls Dr Ste 204, Fairfield, CT 06824 Phone: 203-255-3669 | |
Carla Larracuente, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1300 Post Rd, Suite 204, Fairfield, CT 06824 Phone: 203-255-3669 Fax: 203-255-1173 | |
Taylor Bird, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1931 Black Rock Tpke, Fairfield, CT 06825 Phone: 203-384-8681 Fax: 203-384-0722 | |
Kathleen Istvan, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1931 Black Rock Tpke, Fairfield, CT 06825 Phone: 203-384-8681 Fax: 203-384-0722 |